Company Overview: Moleculin Biotech, Inc. (NASDAQ: MBRX) is a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumours and viruses.
We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy and Terms and Conditions
You are not subscribed for this report, Want to See?
US
AU
UK
CA
NZ